CEBP 09 AM Call for Abstracts w/deadline 09 AM Call for Abstracts w/deadline
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsing, A. W.
Right arrow Articles by Blot, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsing, A. W.
Right arrow Articles by Blot, W. J.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 4 285-288, Copyright © 1994 by American Association for Cancer Research

ARTICLES

Vasectomy and prostate cancer risk in China

AW Hsing, RT Wang, FL Gu, M Lee, T Wang, TJ Leng, M Spitz and WJ Blot
Eidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Maryland 20892.

Vasectomy has been reported to be associated with an increased risk of prostate cancer in western countries. A hospital-based case-control study was conducted in 12 cities in China to evaluate the relationship between vasectomy and prostate cancer risk in China, a low-risk country with rising incidence and increasing use of vasectomy. Interviews were conducted with 138 histologically confirmed prostate cancer cases diagnosed during 1989-1992 and 638 controls (158 hospital cancer, 158 hospital noncancer, and 322 neighborhood controls) of similar ages. Vasectomy at least 10 years prior to interview was reported by 10% of the cases versus 3% of the controls. Odds ratios for prostate cancer associated with vasectomy were 2.0 (95% confidence interval, 0.7-6.1), 3.3 (95% confidence interval, 1.0-11.3), and 6.7 (95% confidence interval, 2.1-21.6), respectively, when hospital cancer, hospital noncancer, and neighborhood controls were used for comparison. Although detection bias is of concern, the data suggest that in China, men with a history of vasectomy may experience an increased risk of prostate cancer.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. M. Lee, S. L. Gomez, J. S. Chang, M. Wey, R.-T. Wang, and A. W. Hsing
Soy and Isoflavone Consumption in Relation to Prostate Cancer Risk in China
Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 665 - 668.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. Cox, M. J. Sneyd, C. Paul, B. Delahunt, and D. C. G. Skegg
Vasectomy and Risk of Prostate Cancer
JAMA, June 19, 2002; 287(23): 3110 - 3115.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. L. Stanford, K. G. Wicklund, B. McKnight, J. R. Daling, and M. K. Brawer
Vasectomy and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 881 - 886.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.